Loading company…
Rempex Pharmaceuticals develops antibacterial drugs for drug-resistant infections.
Founded in 2011, Rempex Pharmaceuticals is focused on discovering and developing antibacterial drugs to address clinical needs caused by multidrug-resistant bacterial pathogens.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in